
OncoRx Insights accelerates access to the most
effective and precise cancer treatments.
See how the bold vision of OncoRx Insights is revolutionizing how oncologists work.
How It Works Our Mission
Utilizing AI technology to bridge relationships between the oncologist, pharmaceutical companies, and patients, giving cancer patients access to rapidly emerging treatments.
Deliver Actionable Insights to Patients, Oncologists, Health Plans and Pharmaceutical Companies


ONCOLOGISTS
PHARMA
HEALTH PLANS


Integrity is at the heart of everything we do – from system design, to providing valuable insights and recommendations, to securing your data.
Our processes are all designed with the same thought in mind: making it easier for oncologists to care for patients.

Orilio didn’t know how long she had to live after her stage-four lung cancer diagnosis. The disease had already infiltrated her eye, so the 31-year-old didn’t bother opening a retirement account.

PJ DiPentino felt uneasy about his local oncologist’s plan. DiPentino’s bladder cancer had returned in a lymph node, and the doctor was recommending he continue immunotherapy and wait to see if it spread.

Personalized medicine presents new opportunities for patients with cancer. However, many patients do not receive the most effective personalized treatments because of challenges associated with integrating predictive biomarker testing into clinical care.

AAVBC event in October 2025. We look forward to seeing you there!

The OncoRx Insights platform enables “one stop shopping” by presenting molecular diagnostic reports from different labs in a common, easily understood format, and integrates the reports and real-time research in one place. The product helps oncologists be more efficient with our time and treatment recommendations. Also, we can use the platform to securely communicate with colleagues regarding NGS reports.

Next generation sequencing reports are long, dense, and complicated. OncoRx Insights translates key findings into easily consumed visuals. This simplifies decisions on potential treatments, indications, side effects and dose modifications. The result? Improved, evidence-based care – and time saved.

The Holy Grail in my world has been understanding the patient journey so that we can solve for whatever issues patients are having along the way. There’s a lot of value there.
